Thursday, 09 April 2026
Watch our on-demand webinar to learn how this groundbreaking in-the-ear style combines discreetness, comfort and ease of use with Oticon’s advanced features. This includes AI sound processing, same-day fitting options, cutting-edge connectivity and rechargeability.
Wednesday, 19 November 2025
At Oticon, we believe hearing care should be as individual as the people who rely on it, which is why our latest offering expands the Oticon Intent™ family with the new Oticon Intent miniBTE R.
Wednesday, 19 March 2025
Our new Oticon Own SI™ offers the discreetness clients want with the audiology they need, thanks to our most advanced platform yet. Meanwhile, new Oticon Jet PX brings DNN to the basic category for the first time.
Tuesday, 20 August 2024
To push the boundaries of hearing technology and improve the lives of people with hearing loss, Oticon strives to remain at the forefront of cognitive hearing research. This means putting our latest hearing aid family, Oticon Intent, to the test.
Wednesday, 20 March 2024
Our latest hearing aid family, Oticon Intent™, is powered by the Sirius™ platform with 4D Sensor technology^ and our Deep Neural Network 2.0. By recognising your client’s listening intentions and seamlessly adapting, it can respond to their individual needs in any situation. This represents a giant leap in our BrainHearing™ technology by providing personalised support, even in complex environments. ^4D Sensor technology only available in Oticon Intent 1 & 2.
Tuesday, 31 October 2023
Audible Contrast Threshold (ACT) is a new test that will enable you to measure a client’s hearing-in-noise abilities, and automatically integrate the appropriate prescription to the hearing aid fitting. ACT takes you beyond the pure-tone audiogram, giving you a fitting rationale for prescribing the right amount of help from the hearing aid in complex, noisy environments.